Company Filing History:

14 out of 2,076

Janssen Pharmaceutica Nv

Years Active: 1987-2013

Loading Chart...

18 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 8557847 - Synergistic modulation of FLT3 kinase using a FLT3 inhibitor and a farnesyl transferase inhibitor (2013-10-15),

2. 8173654 - Triazolopyridazine compounds (2012-05-08),

3. 8071768 - Alkylquinoline and alkylquinazoline kinase modulators (2011-12-06),

4. 8030305 - Triazolopyridazines as kinase modulators (2011-10-04),

5. 7816390 - N-substituted tricyclic 3-aminopyrazoles as anti-mitotic tubulin polymerization inhibitors (2010-10-19),

6. 7795440 - N-substituted tricyclic 1-aminopyrazoles as inhibitors for the treatment of cell proliferative disorders (2010-09-14),

7. 7795279 - Method of inhibiting FLT3 kinase (2010-09-14),

8. 7662824 - Acylhydrazones as kinase modulators (2010-02-16),

9. 7208503 - Angiogenesis inhibiting 5-substituted-1,2,4-thiadiazolyl derivatives (2007-04-24),

10. 7196110 - N-substituted tricyclic 3-aminopyrazoles as inhibitors for the treatment of cell proliferative disorders (2007-03-27),

11. 6833369 - Angiogenesis inhibiting 5-substituted-1,2,4,-thiadiazolyl derivatives (2004-12-21),

12. 6602873 - Angiogenesis inhibiting thiadiazolyl pyridazine derivatives (2003-08-05),

13. 6265407 - Angiogenesis inhibiting thiadiazolyl pyridazine derivatives (2001-07-24),

14. 5985878 - Angiogenesis inhibiting pyridazinamines (1999-11-16),

15. 5294708 - Guanidine derivatives (1994-03-15),

Title: Unveiling the Innovations of Inventor Robert W Tuman

Introduction:

Robert W Tuman, a prolific inventor based in Chalfont, PA (US), has made significant contributions to the field of pharmaceuticals with a total of 18 patents to his name.

Latest Patents:

1. Synergistic modulation of FLT3 kinase using a FLT3 inhibitor and a farnesyl transferase inhibitor: This patent focuses on potent methods for inhibiting FLT3 tyrosine kinase activity in cells, offering new treatment avenues for cell proliferative disorders.

2. Triazolopyridazine compounds: Tuman's invention of these compounds serves as protein tyrosine kinase modulators, specifically targeting c-Met, with potential applications in cancer treatment and other cell proliferative disorders.

Career Highlights:

Tuman's remarkable career includes stints at renowned companies such as Janssen Pharmaceutica N.V. and McNeil AB, underscoring his expertise and experience in the pharmaceutical industry.

Collaborations:

Throughout his career, Tuman has collaborated with esteemed professionals like Dana L Johnson and Raymond A Stokbroekx, fostering a culture of innovation and teamwork in his research endeavors.

Conclusion:

Inventor Robert W Tuman's groundbreaking patents in pharmaceuticals showcase his unwavering commitment to advancements in treating cell proliferative disorders. His collaborations and career highlights emphasize his invaluable contributions to the field, paving the way for future innovations in the industry.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

3 patents (CIPO):

Please report any incorrect information to support@idiyas.com

2 patents (EPO):

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.